Who owns Roivant Sciences Ltd. (ROIV)? Elite investor 13F holders
7 tracked elite investors reported holding Roivant Sciences Ltd as of 2026-06-30, including Viking Global Investors, Rubric Capital, D.E. Shaw, Maverick Capital, Greenlight Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Viking Global Investors | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 221947217.00 USD | 6271467.000000 | Shares | reduce | Original filing |
| Rubric Capital | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 212340000.00 USD | 6000000.000000 | Shares | add | Original filing |
| D.E. Shaw | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 105203924.00 USD | 2972702.000000 | Shares | add | Original filing |
| Maverick Capital | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 100119159.00 USD | 2829024.000000 | Shares | add | Original filing |
| Greenlight Capital | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 76182956.00 USD | 2152669.000000 | Shares | hold | Original filing |
| Gotham Asset Management | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 47757566.00 USD | 1349465.000000 | Shares | reduce | Original filing |
| Polen Capital Management | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 306442.00 USD | 8659.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.